TAROU EDAHIRO

Last Updated :2024/02/01

Affiliations, Positions
Hiroshima University Hospital(Medical), Assistant Professor
E-mail
tedahirohiroshima-u.ac.jp
Self-introduction
haematologist Research subject: achieving the practical use of genetically modified T-cell for the treatment

Basic Information

Academic Degrees

  • Hiroshima University

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Hematology

Research Keywords

  • transplantation
  • hematopoietic stem cells
  • hematological malignancy
  • Lymphoid malignancies

Affiliated Academic Societies

  • The Japanese Society of Internal Medicine
  • Japanese Society of Hematology
  • Japanese Society for Transplantation and Cellular Therapy

Educational Activity

Course in Charge

  1. 2023, Undergraduate Education, Intensive, Practice of Medicine I

Research Activities

Academic Papers

  1. Successful treatment of acute chest syndrome with manual exchange transfusion in a patient with sickle beta+-thalassemia., Intern Med., 58(11), 1629-1634
  2. CD56-positive B-cell precursor acute lymphoblastic leukemia harboring KMT2A-AFF1 rearrangement developed in a pregnant woman successfully treated with allogeneic hematopoietic cell transplantation., J Hematopathol, 13(4), 47-49
  3. Streptococcus gallolyticus ssp. pasteurianus bacteremia during chemotherapy induced neutropenia in a patient with malignant lymphoma., Hiroshima Journal of Medical Science, 69(2), 47-50, 20200630
  4. Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis, HEMATOLOGY, 26(1), 186-198, 202112
  5. Progressive Multifocal Leukoencephalopathy in Relapsed Ph plus Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review, ACTA HAEMATOLOGICA, 145(6), 655-660, 2022
  6. Successful combination treatment with azacitidine and venetoclax for a patient with acute myeloid leukemia undergoing hemodialysis., Leuk Lymphoma, 63(14), 3511-3512, 202212
  7. Successful combination treatment with azacitidine and venetoclax as a bridging therapy for third allogenic stem cell transplantation in a patient with 11q23/MLL-rearranged complex karyotype acute myeloid leukemia., EJHaem, 4(1), 273-375, 20221226

Invited Lecture, Oral Presentation, Poster Presentation

  1. Is it necessary to perform the central nervous system prophylaxis in primary cardiac lymphoma?, Taro Edahiro, Noriyasu Fukushima, Ren Chishaki, Tetsumi Yoshida, Tatsuji Mino, Sayaka Sugihara, Masatoshi Nishizawa, Tatsuo Ichinohe, The 83rd Annual Meeting of the Japanese Society of Hematology, 2021/09/23, Without Invitation, English, Japanese Society of Hematology, Sendai(Virtual)
  2. The management of concurrent plasma cell myeloma and breast cancer., Taro Edahiro, Noriyasu Fukushima, Tetsumi Yoshida, Takakazu Kawase, Yoshiki Fujioka, Ren Chishaki, Tatsuji Mino, Sayaka Sugihara, Hisao Nagoshi, Ai Amioka, Masatoshi Nishizawa, Tatsuo Ichinohe, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, English, Japanese Society of Hematology, Kyoto(Virtual)